Oncolytics Biotech's total assets for Q3 2025 were C$15.06M, a decrease of -24.62% from the previous quarter. ONCY total liabilities were C$14.94M for the fiscal quarter, a 7.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.